A study for a 67 year old man who takes Epclusa, Lantus, Oxycodone - from FDA reports


Summary

271 males aged 67 (±5) who take the same drugs are studied. This is a personalized study for a 67 year old male patient who has Hepatitis C, Diabetic Type 2, Low Back Pain. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Dec, 02, 2017

271 males aged 67 (±5) who take Epclusa, Lantus, Oxycodone are studied.


Number of reports submitted per year:

Epclusa, Lantus, Oxycodone for a 67-year old man.

Information of the patient in this study:

  • Age: 67
  • Gender: male
  • Conditions: Hepatitis C, Diabetic Type 2, Low Back Pain
  • Drugs taken:
    • Epclusa (sofosbuvir; velpatasvir)
    • Lantus (insulin glargine recombinant)
    • Oxycodone (oxycodone hydrochloride)

eHealthMe real world results:

Most common drug interactions over time

< 1 month:
  • pneumonia
  • hepatic encephalopathy
  • sjogren syndrome
  • urinary incontinence
  • carpal tunnel syndrome
  • fall
  • trigger finger
  • nerve injury
  • angioedema
  • nausea
1 - 6 months:
  • nausea
  • subarachnoid haemorrhage
  • drug ineffective
  • abdominal pain
  • abdominal discomfort
  • febrile bone marrow aplasia
  • feeding disorder
  • pneumonia
  • malaise
  • hypogeusia
6 - 12 months:
  • respiratory acidosis
  • heart attack
  • disseminated intravascular coagulation
  • mental status changes
  • metastatic renal cell carcinoma
  • pulmonary haemorrhage
  • hypoglycemia
  • disease progression
  • thrombocytopenia
  • hypotension
1 - 2 years:
n/a
2 - 5 years:
  • haemorrhagic stroke
  • breathing - slowed or stopped
  • fall
  • skin - clammy
  • high blood pressure
  • malaise
  • brain death
  • insomnia
  • bleeding disorders
  • feeling abnormal
5 - 10 years:
  • haemorrhagic stroke
  • fall
  • breathing - slowed or stopped
  • skin - clammy
  • high blood pressure
  • malaise
  • brain death
  • insomnia
  • bleeding disorders
  • abnormal behavior
10+ years:
  • thrombosis
  • pulmonary embolism
not specified:
  • fatigue
  • nausea
  • breathing difficulty
  • nausea and vomiting
  • pneumonia
  • weakness
  • thrombocytopenia
  • hypotension
  • back pain
  • constipation

Top conditions involved for these people *:

  • Insomnia (35 people, 12.92%)
  • High Blood Pressure (35 people, 12.92%)
  • Multiple Myeloma (34 people, 12.55%)
  • Neuropathy Peripheral (27 people, 9.96%)
  • Micturition Disorder (22 people, 8.12%)

Top co-used drugs for these people *:

  • Novolog (66 people, 24.35%)
  • Lasix (58 people, 21.40%)
  • Humalog (53 people, 19.56%)
  • Metformin (46 people, 16.97%)
  • Aspirin (43 people, 15.87%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

Related studies:

Can you answer these questions?

More questions for: Low back pain, Lantus, Diabetic type 2, Oxycodone, Hepatitis c, Epclusa

You may be interested in these reviews

More reviews for: Low back pain, Lantus, Diabetic type 2, Oxycodone, Hepatitis c, Epclusa